<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                                        Europe PMC Funders Group <br />                                         Author Manuscript <br />                                         Cell. Author manuscript; available PMC 2015 April 14. <br />                                                <br />  <br />                                               eEF2 Kinase Confers Resistance Nutrient Deprivation                                               Blocking Translation Elongation <br />                                               Gabriel Leprivier1, Marc Remke2,3,4, Barak Rotblat1, Adrian Dubuc2,3, Abigail-Rachele F. <br />                                               Mateo3,6, Marcel Kool4, Sameer Agnihotri2, Amal El-Naggar1, Bin Yu6, Syam Prakash <br />                                               Somasekharan1, Brandon Faubert7, Ga&#195;&#171;lle Bridon8, Cristina E. Tognon1, Joan Mathers1, <br />                                               Ryan Thomas1, Amy Li1, Adi Barokas1, Brian Kwok1, Mary Bowden9, Stephanie Smith9, <br />                                               Xiaochong Wu2,3, Andrey Korshunov10, Thomas Hielscher5, Paul  Northcott2, Jason D. <br />                                               Galpin11, Christopher  Ahern11, Ye Wang12, Martin G. McCabe13,14, V. Peter Collins14, <br />                                               Russell G. Jones7, Michael Pollak12, Olivier Delattre15, Martin E. Gleave9, Eric Jan16, Stefan <br />                                               M. Pfister4,17, Christopher G. Proud18, W. Brent Derry3,6, Michael D. Taylor2,3, Poul H. <br />                                               Sorensen1,* <br />                                               1Department  Molecular Oncology, British Columbia Cancer Research Centre Department <br />                                               Pathology, University British Columbia (UBC), Vancouver, BC V5Z1L4, Canada <br />                                               2TheArthur Sonia Labatt Brain Tumor Research Centre Division Neurosurgery, <br />                                               Hospital Sick Children (HSC), University Toronto, M5G1L7, Canada <br />                                               3Program     Developmental Stem Cell Biology, HSC, University Toronto, M5G1X8, <br />                                               Canada <br />                                               4Divisionof Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120 <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                               Heidelberg, Germany <br />                                               5Division   Biostatistics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany <br />                                               6Department      Molecular Genetics, University Toronto, M5G2M9, Canada <br />                                               7Goodman Cancer Research Centre, Department Physiology, McGill University, Montreal, QC <br />                                               H3G1Y6, Canada <br />                                               8Metabolomics <br />                                                           Core Facility, Goodman Cancer Research Centre, McGill University, Montreal, QC <br />                                               H3A1A3, Canada <br />                                               9Departmentof Urological Sciences, UBC Vancouver Prostate Centre, Vancouver, BC <br />                                               V6H3Z6, Canada <br />                                               10Department       Neuropathology, University Heidelberg, DKFZ, 69120 Heidelberg, Germany <br />                                               11Department       Molecular Physiology Biophysics, University Iowa, Iowa City, IA 52242, <br />                                               USA <br />  <br />  <br />  <br />                                               &#194;&#169;2013 Elsevier  <br />                                               * <br />                                                Correspondence: psor@mail.ubc.ca. <br />                                               SUPPLEMENTAL INFORMATION <br />                                               Supplemental Information includes Extended Experimental Procedures seven figures article online                                               http://dx.doi.org/10.1016/j.cell.2013.04.055. <br />                                          Leprivier et al.                                                                                             Page 2 <br />  <br />                                             12Lady    Davis Research Institute McGill University, Montreal, QC H3T1E2, Canada <br />                                             13School       Cancer Enabling Sciences, University Manchester, Manchester M204BX, UK <br />                                             14Department       Pathology, University Cambridge, Cambridge CB21QP, UK <br />                                             15INSERM        U830, Laboratoire G&#195;&#169;n&#195;&#169;tique et Biologie des Cancers, Institut Curie, 75248 Paris, <br />                                             France <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                             16Department       Biochemistry Molecular Biology, UBC, Vancouver, BC V6T1Z3, Canada <br />                                             17Department  Pediatric Oncology, Hematology Immunology, University Hospital <br />                                             Heidelberg, 69120 Heidelberg, Germany <br />                                             18Centre       Biological Sciences, University Southampton, Southampton SO171BJ, UK <br />  <br />                                             SUMMARY <br />                                                   Metabolic adaptation essential cell survival nutrient deprivation. report                                                   eukaryotic elongation factor 2 kinase (eEF2K), activated <span id='am-16' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-17' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-19' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span>AMP</span>-kinase (AMPK), <br />                                                   confers cell survival acute nutrient depletion blocking translation elongation. Tumor cells <br />                                                   exploit pathway adapt nutrient deprivation reactivating AMPK-eEF2K axis. <br />                                                   Adaptation transformed cells nutrient withdrawal severely compromised cells lacking <br />                                                   eEF2K.  eEF2K knockdown restored sensitivity acute nutrient deprivation highly <br />                                                   resistant human tumor cell lines. vivo, overexpression eEF2K rendered murine tumors <br />                                                   remarkably resistant caloric restriction. Expression eEF2K strongly correlated overall <br />                                                   survival human medulloblastoma glioblastoma multiforme. Finally, C. elegans strains <br />                                                   deficient efk-1, eEF2K ortholog, severely compromised response nutrient <br />                                                   depletion. data highlight conserved role eEF2K protecting cells nutrient <br />                                                   deprivation conferring tumor cell adaptation metabolic stress. <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                             INTRODUCTION <br />                                                                Nutrient deprivation (ND) severe physiological stress dire consequences cell <br />                                                                viability. Living organisms evolved molecular mechanisms respond ND, <br />                                                                including metabolic reprogramming preserve energy balance (Caro-Maldonado                                                                Mu&#195;&#177;oz-Pinedo, 2011). key mediator highly conserved energy sensor AMP-activated <br />                                                                protein kinase (AMPK), activated cellular AMP:<span id='am-28' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-29' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-33' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-36' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-38' property="rdfs:label" content="ATP" datatype="xsd:string"></span>ATP</span> <span id='am-10' about='obo:IMR_0001360' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-11' property="rdfs:label" content="ADP" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasAlternativeId" content="IMR:0200375" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:id" content="IMR:0001360" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasDbXref" content="KEGG:C00008" datatype="xsd:string"></span>ADP</span>:ATP ratios <br />                                                                increase (Hardie, 2011). AMPK limits energy-consuming processes proliferation <br />                                                                protein synthesis induces catabolic processes glycolysis fatty acid <br />                                                                oxidation preserve energy (Hardie, 2011). critical nutrient sensor mammalian <br />                                                                target <span id='am-5' about='obo:IMR_0002818' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-6' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-7' property="oboInOwl:hasDbXref" content="KEGG:C07909" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:id" content="IMR:0002818" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="rapamycin" datatype="xsd:string"></span>rapamycin</span> complex 1 (mTORC1), regulated ATP <span id='am-49' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-50' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-51' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-52' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-53' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-55' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span>amino acid</span> <br />                                                                levels (Zoncu et al., 2011). complex couples nutrient abundance control protein <br />                                                                synthesis phosphorylation 4EBP1 p70S6K (Hay Sonenberg, 2004). <br />                                                                nutrient availability compromised, mTORC1 inactivated, AMPK <br />                                                                (Inoki et al., 2003), blocking protein synthesis, energy-demanding process <br />                                                                cell (Buttgereit Brand, 1995). <br />  <br />  <br />  <br />  <br />                                                                        Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                            Page 3 <br />  <br />  <br />                                                            Pathologic ND occurs hypoxia early stages tumor development new <br />                                                            blood vessels form later stages abnormal tumor vasculature (Nagy et al., 2009). <br />                                                            metabolic stress prevents tumor development inducing growth arrest necrosis, <br />                                                            select metabolically adapted cells form aggressive tumors (Jones                                                            Thompson, 2009). Proto-oncogenes MYC, AKT, mTOR stimulate anabolic <br />                                                            metabolism sensitize cells ND (Buzzai et al., 2005; Choo et al., 2010; Shim et al., 1998). <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            argues  balance initial oncogenic events driving energy-demanding processes <br />                                                            proliferation, tumors develop adaptive responses protect cells ND <br />                                                            (Jones Thompson, 2009). factors linked responses, including <br />                                                            ATF4, NF&#206;&#186;B, CPT1C, affect amino acid synthesis, mitochondrial respiration, <br />                                                            fatty acid oxidation, respectively (Mauro et al., 2011; Ye et al., 2010; Zaugg et al., <br />                                                            2011).  understanding process incomplete, uncovering                                                            molecular pathways involved critical potential therapeutic targeting tumors. <br />  <br />                                                            study, report eukaryotic translation elongation factor 2 kinase (eEF2K)                                                            conserved mediator cellular response ND. EEF2K inhibits activity translation <br />                                                            elongation factor eEF2, mediates translocation stage translation elongation, <br />                                                            polypeptidyl-tRNAs P site ribosome (Carlberg et al., <br />                                                            1990). Activity eEF2K tightly controlled nutrient availability, notably direct <br />                                                            positive regulation AMPK inhibition mTORC1 Ras-Erk-p90RSK pathways <br />                                                            (Proud, 2007). absence nutrients, eEF2K activated phosphorylate                                                            inactivate eEF2 (Ryazanov et al., 1988), blocking energy-demanding messenger <br />                                                            RNA (mRNA) translation elongation (Carlberg et al., 1990). data demonstrate critical <br />                                                            role eEF2K protecting normal tissues acute ND inhibition eEF2                                                            pathway exploited tumor cells adapting metabolic stress. <br />  <br />  <br />                                             RESULTS <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                             Oncogenic Transformation Sensitizes Fibroblasts Acute ND Association                                             Defective eEF2 Signaling <br />                                                            tested effects oncogenic transformation responses acute ND using National <br />                                                            Institutes Health (NIH) 3T3 fibroblasts transformed activated K-RasV12 (RasV12)                                                            ETV6-NTRK3   chimeric tyrosine kinase (Knezevich et al., 1998).                                                            oncoproteins constitutively activate Ras-Erk PI3K-Akt (Tognon et al., 2002), allowing <br />                                                            study pathways impact acute responses ND. Transformed fibroblasts <br />                                                            cultured media lacking glucose, amino acids, serum showed massive cell death <br />                                                            compared nontransformed control cells ND (Figures 1A S1A available online). <br />                                                            Apoptosis confirmed Annexin V staining (Figure S1B). Glucose depletion                                                            induced cell death transformed cells, amino acid depletion little effect <br />                                                            (Figure S1C).  withdrawal glucose amino acids significantly <br />                                                            enhanced cell death transformed cells (Figure S1C). Increased cell death linked                                                            increased proliferation reactive oxygen species (ROS), similarly reduced                                                            increased, respectively, control transformed cells ND (Figures S1D S1E). <br />                                                            Acute ND precipitously reduced ATP levels control cells,  unexpectedly,                                                            observed transformed cells (Figure S1F), arguing severe energetic crisis  <br />  <br />  <br />                                                                     Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                           Page 4 <br />  <br />  <br />                                                             Finally, autophagy similarly induced cell lines based LC3-II <br />                                                            accumulation (data shown), ruling differential autophagy flux basis                                                            observed phenotype. <br />  <br />                                                            assessed mTORC1 signaling, rapidly profoundly inhibited                                                            cell lines ND (Figure 1C).  activation key energy sensor, <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            AMPK, compromised transformed cells ND, indicated reduced <br />                                                            phosphorylation AMPK acetyl <span id='am-39' about='obo:IMR_0200354' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-40' property="oboInOwl:id" content="IMR:0200354" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:hasDbXref" content="KEGG:C00010" datatype="xsd:string"></span><span id='am-42' property="rdfs:label" content="CoA" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>CoA</span>-carboxylase (ACC) (Figure 1C).  <br />                                                            phosphorylation eEF2 Thr56, known marker AMPK activation, markedly <br />                                                            blunted ND transformed versus control cells (Figure 1C). EEF2 essential                                                            translation elongation (Buttgereit Brand, 1995), Thr56 phosphorylated eEF2 <br />                                                            kinase (eEF2K), known kinase eEF2, block eEF2 activity (Carlberg et al., <br />                                                            1990). suggested eEF2 activity partially retained transformed cells                                                            ND. addition, phosphorylation eEF2K Ser366, catalyzed p90RSK downstream                                                            Ras-Erk inhibit eEF2K (Wang et al., 2001), retained transformed cells ND <br />                                                            (Figure 1C). <br />  <br />                                                            results point eEF2K inhibition deregulated eEF2 activity transformed cells <br />                                                            ND. examined contributions Ras-Erk-p90RSK AMPK                                                            process, regulate eEF2K (Proud, 2007). <span id='am-1' about='obo:IMR_0000947' typeof='owl:Thing obo:IMR_0000001'><span id='am-2' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:id" content="IMR:0000947" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="chemical" datatype="xsd:string"></span>Chemical</span> inhibitors p90RSK (PD184352 <br />                                                            BI-D1870; data shown) dominant-negative p90RSK (DN-RSK; Figure S1G)                                                            reduced eEF2K-Ser366 phosphorylation markedly enhanced eEF2 phosphorylation                                                            RasV12 cells ND.  ectopically activated AMPK ND using <br />                                                            AICAR SMER28, chemical inducers AMPK, constitutively active AMPK.                                                            strongly induced eEF2 phosphorylation changing eEF2K mRNA (data shown) <br />                                                            protein levels (Figures S2A S2B).  eEF2K activity deregulated                                                            transformed cells ND sustained Ras-Erk-p90RSK activity reduced AMPK <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            activation. likely occurs constitutively high Ras activity RasV12                                                            transformed cells (Figure 1C). explore basis defective AMPK activation,                                                            measured AMP:ATP ADP:ATP ratios, known physiological inducers AMPK <br />                                                            (Hardie, 2011), ATP levels elevated transformed cells (Figure S1F). <br />                                                            ratios elevated control cells ND correlated AMPK <br />                                                            induction (Figure 1C), ratios virtually unchanged transformed cells (Figures 1D                                                            S2C).  RasV12-transformed cells unexpectedly exhibit defect                                                            energy response ND maintaining high ATP failing raise AMP:ATP                                                            ADP:ATP ratios. confirm sustained ATP levels inhibit AMPK activation,                                                            blocked ATP production 2-deoxyglucose (2-DG) rotenone. agents,                                                            Akt inhibitor, induced AMPK activity ND markedly increased eEF2 <br />                                                            phosphorylation (Figure 1E).  indicates transformation sensitizes <br />                                                            fibroblasts ND association defects AMPK p90RSK regulation eEF2. <br />  <br />                                             Adaptation Transformed Cells Chronic ND Correlates Increased AMPK-eEF2K <br />                                             Pathway Activation <br />                                                            hypothesized rare transformed cells adapt acquire resistance                                                            prolonged ND.  transformed cells subjected repeated cycles prolonged <br />  <br />  <br />  <br />                                                                     Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                          Page 5 <br />  <br />  <br />                                                            ND followed nutrient resupplementation (Figure 1F Extended Experimental <br />                                                            Procedures).  weeks, stable populations &#226;&#8364;&#339;selected&#226;&#8364;? RasV12 <br />                                                            cells, designated selected  S) RasV12 selected (RasV12-S), respectively, emerged <br />                                                            capacity survive acute ND (Figure 1F), retained multiple <br />                                                            passages (tested serial passages). Importantly, unselected  RasV12- <br />                                                            transformed cells subjected adaptation protocol glucose amino <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            acids  S+Glc+AA RasV12-S+Glc+AA), equally sensitive ND parental <br />                                                            counterparts (Figure S2D), indicating adaptive reprogramming requires chronic <br />                                                            exposure ND. Notably, S RasV12-S cells retained soft-agar-colony-forming <br />                                                            activity (data shown) tumorigenicity (Figure S2E). observed unselected cells, <br />                                                            S RasV12-S cells rapidly shut mTORC1 signaling acute ND                                                            exhibited similar levels Akt activation autophagic flux compared unselected <br />                                                            counterparts (Figures 1G S2F). contrast, displayed increased AMPK ACC <br />                                                            phosphorylation ND, suggesting  like non-transformed cells, selected cells                                                            reacquired ability activate AMPK ND (Figure 1G). correlated                                                            massively increased eEF2 phosphorylation, altered eEF2K transcript <br />                                                            protein levels (Figures 1G S2G). confirms correlation eEF2 <br />                                                            phosphorylation survival capacity acute ND. inhibition                                                            Ras-Erk-p90RSK pathway, eEF2K Ser366 phosphorylation preserved selected <br />                                                            cells ND (Figure 1G).  blocking AMPK activity dominant-negative <br />                                                            AMPK (DN-AMPK) markedly reduced eEF2 phosphorylation selected cells (Figure 1H) <br />                                                            significantly increased ND-induced cell death (Figure 1I), highlighting importance <br />                                                            AMPK reinduction resistance ND. Mechanistically, changes                                                            LKB1 expression (Figure 1G), directly activates AMPK (Hardie, 2011).  <br />                                                            AMP:ATP ADP:ATP ratios markedly increased S RasV12-S cells <br />                                                            ND compared parental RasV12 cells (Figures 1D S2C).  <br />                                                            unlike nonselected tumor cells, selected cells able raise AMP:ATP ADP:ATP <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            ratios nutrient depleted, strongly suggesting adaptation RasV12 cells                                                            ND linked reactivation AMPK-eEF2K axis. <br />  <br />                                             Translation Elongation Deregulated Transformed Fibroblasts ND Restricts <br />                                             Cell Survival <br />                                                            asked eEF2 deregulation impacts protein synthesis ND, predicting <br />                                                            high eEF2 activity sustain protein synthesis ND, sensitizing <br />                                                            nonselected tumor cells apoptosis.  rates global protein synthesis                                                            equivalently reduced ND transformed nontransformed cells using [35S]- <br />                                                            methionine/cysteine incorporation (Figure 2A) pulse-labeling L-azidohomoalanine <br />                                                            (AHA) (Somasekharan et al., 2012) (Figure S3A). consistent observed block <br />                                                            mTORC1 signaling ND (Figure 1C) argues major role sustained <br />                                                            global protein synthesis hypersensitivity nonselected transformed cells ND.                                                            noteworthy low level protein synthesis observed 6 hr ND <br />                                                            (Figure S3B). <br />  <br />                                                            examined effects ND translation initiation versus elongation analyzing <br />                                                            polysome profiles sucrose gradients. Ribosomal 40S-, 60S-, 80S-mRNA <br />  <br />  <br />                                                                    Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                            Page 6 <br />  <br />  <br />                                                            complexes represent translationally inactive complexes (subpolysomal fractions),                                                            polyribosome (polysome) fractions correspond translationally active complexes. ND <br />                                                            markedly increased 60S fractions control transformed cells, indicating global <br />                                                            block translation initiation (Figure 2B). consistent loss 4EBP1 <br />                                                            phosphorylation (Figure 1C), blocks cap-dependent translation initiation, major <br />                                                            rate-limiting step mRNA translation (Mathews et al., 2007). ratios polysomal <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            subpolysomal fractions (P/S) significantly affected ND nontransformed <br />                                                            cells (4% &#194;&#177; 0.2% reduction), P/S ratios dramatically decreased RasV12 cells <br />                                                            (82% &#194;&#177; 2% 91% &#194;&#177; 3%, respectively) ND (Figure 2B). initiation                                                            blocked, strongly suggests  transformed cells, ribosomes continuously <br />                                                            running transcripts  e., minimal ribosome stalling) ND, leading                                                            polysomal disaggregation sustained translation elongation, decreasing P/S ratios <br />                                                            (Mathews et al., 2007). Furthermore, ND, eEF2 remained unphosphorylated <br />                                                            state mouse embryonic fibroblasts (MEFs) lacking eEF2K (eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217;), indicating                                                            translation elongation maintained eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217; cells ND, contrast wild-type <br />                                                            eEF2K+/+ cells eEF2 strongly phosphorylated (Figure S3C). ND correlated <br />                                                            accumulation 60S fractions eEF2K+/+ eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217; cells,                                                            consistent blocked translation initiation (Figure S3D).  P/S ratio                                                            dramatically reduced ND eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217; cells (89% &#194;&#177; 2%) compared eEF2K+/+ cells <br />                                                            (49% &#194;&#177; 1%) (Figure S3D). indicates retained eEF2 activity leads sustained <br />                                                            translation elongation polysome disaggregation ND. <br />  <br />                                                            conclusively demonstrate differential translation elongation control versus transformed <br />                                                            cells, measured ribosome half-transit times ND. refer time required <br />                                                            ribosome translate average-sized mRNA inverse elongation rate <br />                                                            (Fan Penman, 1970). ND, ribosome half-transit times ~2-fold longer                                                            nontransformed cells, indicative slower elongation rates (Figure 2C). contrast, <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            half-transit times slightly increased ND RasV12 cells  e., ~1.25- <br />                                                            fold ~1.2-fold, respectively) (Figure 2C). differences intracellular <br />                                                            amino acid levels control transformed cells, decreased equivalently <br />                                                            ND (Figure S3E). data support model  nonselected tumor cells <br />                                                            ND, retained eEF2 activity leads sustained translation elongation. link                                                            cell death ND, specifically impaired translation elongation RasV12 cells <br />                                                            eEF2 knockdown (Figure 2D).  ND-induced cell death substantially reduced <br />                                                            transformed cells eEF2 knockdown compared small interfering RNA (siRNA) <br />                                                            controls (Figure 2E). supports role deregulated eEF2 activity                                                            hypersensitivity transformed cells ND. addition, S/DN-AMPK RasV12- <br />                                                            S/DN-AMPK cells, highly susceptible ND (Figure 1I), rescued cell <br />                                                            death eEF2 knockdown, suggesting AMPK promotes survival adapted <br />                                                            transformed cells inhibiting translation elongation (Figures 2F 2G).  <br />                                                            sustained translation elongation renders transformed cells hypersensitive ND. <br />  <br />                                             eEF2K Critical Cell Survival ND <br />                                                            translation elongation tightly controlled eEF2K (Carlberg et al., 1990),                                                            examined impact eEF2K expression cell survival ND. Similar  <br />  <br />                                                                     Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                          Page 7 <br />  <br />  <br />                                                            nonselected tumor cells, eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217; MEFs highly sensitive ND compared                                                            eEF2K+/+ MEFs underwent apoptotic cell death ND (Figures 3A S4A).                                                            contrast previous reports (Wu et al., 2006), associated defects                                                            autophagy (Figures S4B S4C). establish eEF2 linked survival <br />                                                            responses ND, performed eEF2 knockdown eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217; cells, harbor high <br />                                                            eEF2 activity ND (Figure S3C). markedly increased cell survival compared Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            siRNA controls (Figures 3B 3C).  eEF2K knockdown NIH 3T3 cells                                                            independent eEF2K siRNAs strongly sensitized cells ND (Figures 3D 3E). <br />                                                             coknockdown eEF2 completely rescued cells cell death (Figures 3D                                                            3E), confirming eEF2K mediates survival ND control eEF2. <br />                                                            Conversely, stable overexpression eEF2K  RasV12-transformed NIH 3T3 cells <br />                                                            led increased eEF2 phosphorylation cell survival ND (Figures 3F 3G).                                                            observed kinase-dead eEF2K, implying eEF2 phosphorylation                                                            inhibition translation elongation critical survival ND (Figures 3G S4D). <br />  <br />                                                            directly test role eEF2K adaptive response transformed fibroblasts ND, <br />                                                            performed eEF2K knockdown S RasV12-S cells  high phospho- <br />                                                            eEF2 levels; Figure 1G) using independent siRNAs. blocked eEF2 phosphorylation <br />                                                            (Figure 3H) rendered cells significantly susceptible ND compared siRNA <br />                                                            control cells (Figure 3I). Finally, eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217; MEFs transformed RasV12 exhibited <br />                                                            similar growth vitro ambient conditions eEF2K+/+ counterparts (Figures <br />                                                            S4E S4F) similarly tumorigenic athymic mouse (Figure S4G).  <br />                                                            cells subjected adaptation protocol (Figure 1F), transformed <br />                                                            eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217; MEFs strikingly reduced capacity adapt repeated ND compared                                                            transformed eEF2K+/+ MEFs (Figure 3J). findings clearly establish eEF2K                                                            critical survival factor ND adaptive response transformed fibroblasts                                                            nutrient stress. <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                             eEF2K Critical Survival Human Tumor Cells Nutrient Stress <br />                                                            extend findings human cells, screened tumor cell lines eEF2 <br />                                                            phosphorylation ND. identified lines widely divergent levels: HeLa <br />                                                            cells showed minimal eEF2 phosphorylation, MG63 osteosarcoma cells exhibited <br />                                                            high eEF2 phosphorylation ND (Figure 4A). HeLa cells exhibited extremely low <br />                                                            AMPK activity ND reported (Liang et al., 2007),  MG63 cells, AMPK <br />                                                            activity high (Figure 4A). tightly associated survival: HeLa cells                                                            highly sensitive ND, MG63 cells completely resistant cell death <br />                                                            conditions (Figures 4B 4C), HeLa cells particularly sensitive                                                            glucose withdrawal (Figure S5A). link eEF2 translation elongation,                                                            knocked eEF2 HeLa cells, significantly reduced cell death ND <br />                                                            compared siRNA controls (Figures 4D 4E).  stable eEF2K overexpression <br />                                                            increased eEF2 phosphorylation cell survival HeLa cells ND compared                                                            parental cells (Figures 4F, 4G, S5B). strongly argues hypersensitivity HeLa <br />                                                            cells related reduced eEF2K activity sustained translation elongation. Knockdown <br />                                                            eEF2K, reduced eEF2 phosphorylation compared controls (Figure 4H), strongly <br />                                                            increased sensitivity MG63 cells ND (Figures 4I S5C). phenocopied  <br />  <br />                                                                    Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                          Page 8 <br />  <br />  <br />                                                            knockdown AMPK-subunits &#206;&#177;1/&#206;&#177;2, sensitized MG63 cells ND-induced cell <br />                                                            death, supporting importance AMPK-eEF2K axis protecting human tumor cells <br />                                                            ND (Figures S5D S5E). Overall, results demonstrate eEF2K critical <br />                                                            survival human tumor cells ND. <br />  <br />                                             eEF2K Protects Tumors Caloric-Restriction-Induced Cell Death Vivo <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            determine relevance findings vivo,  RasV12-transformed NIH 3T3 <br />                                                            cells overexpressing eEF2K MSCV vector control subcutaneously implanted                                                            nu/nu immunocompromised mice. Mice fed standard ad libitum (AL) diet  <br />                                                            prior tumor development, caloric restriction (CR) corresponding 60% caloric intake                                                            AL diet. described (Kalaany Sabatini, 2009), CR led significant reductions                                                            blood IGF1, insulin, glucose levels (Figures S6A&#226;&#8364;&#8220;S6C). Tumor sizes RasV12 <br />                                                            vector control mice severely reduced  ~50%) CR compared AL <br />                                                            (compare MSCV bars Figures 5A 5B). eEF2K-overexpressing tumors                                                            smaller control tumors AL diets, likely reduced translation elongation                                                            overall growth, sizes virtually unaffected CR (Figures 5A, 5B,                                                            S6D). Notably, eEF2K RasV12/eEF2K tumors eventually grew larger sizes                                                            controls mice reverted AL diet following CR (Figures S6E S6F), <br />                                                            highlighting survival advantage high eEF2K expression tumors. Morphologic <br />                                                            examination revealed massive necrosis RasV12 vector control tumors                                                            CR compared AL diets. dramatic contrast, eEF2K RasV12/eEF2K tumors                                                            CR animals exhibited apparent necrosis (Figures 5C S6G). RasV12 control <br />                                                            tumors, CR massively increased apoptosis measured IHC cleaved caspase-3,                                                            observed eEF2K RasV12/eEF2K tumors (Figures 5D S6H),                                                            accentuating protective effect eEF2K vivo. assessed eEF2K activity AL <br />                                                            versus CR tumors analyzing phospho-eEF2 levels IHC immunoblotting. <br />                                                            Phosphorylation eEF2 poorly induced CR RasV12 control tumors  Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            MSCV panels Figures 5E, 5F, S6I, S6J), correlated sustained eEF2K <br />                                                            inhibition CR indicated retention p90RSK-mediated eEF2K Ser366- <br />                                                            phosphorylation (Figure S6K). contrast, eEF2 phosphorylation strongly induced                                                            eEF2K RasV12/eEF2K tumors AL CR pronounced <br />                                                            CR  eEF2K panels Figures 5E, 5F, S6I, S6J). confirmed                                                            CR using eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217; +/+ MEFs transformed RasV12 (Figure S6L). tumor <br />                                                            sizes reduced CR RasV12/eEF2K+/+ MEF tumors, effects significant <br />                                                            RasV12/eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217; MEF tumors (Figure 5G). CR led significantly increased <br />                                                            necrosis apoptosis RasV12/eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217; compared RasV12/eEF2K+/+ tumors <br />                                                            (Figures 5H 5I), indicating genetic loss eEF2K increases sensitivity                                                            tumors CR. results consistent model eEF2K activity protects <br />                                                            tumors CR-induced cell death vivo. <br />  <br />                                             Expression eEF2K Associated Poor Prognosis Medulloblastoma                                             Glioblastoma Multiforme <br />                                                            probe findings primary human tumors, focused medulloblastoma (MB), <br />                                                            common malignant brain tumor childhood, glioblastoma multiforme <br />                                                            (GBM), highly malignant adult brain tumor, eEF2K expression data  <br />  <br />                                                                    Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                            Page 9 <br />  <br />  <br />                                                            publically available tumors (Northcott et al., 2011). MB, high eEF2K transcript <br />                                                            levels correlated aggressive metastatic subtype MB, group 3 <br />                                                            tumors (Northcott et al., 2011). Gene expression profiles independent MB cohorts <br />                                                            (total n = 286) demonstrated highly significant upregulation eEF2K group 3 relative                                                            non-group-3 tumors (Figures 6A 6B). Furthermore, high eEF2K expression correlated <br />                                                            significantly decreased overall survival disease variants (p = 0.00003; Figure 6C), <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            aggressive non-WNT/non-SHH subtypes (p = 0.002; Figure 6D). EEF2K <br />                                                            expression significantly upregulated GBM compared normal human brain tissue <br />                                                            (~2.5-fold; Figure 6E). GBM subtypes, eEF2K expression specifically <br />                                                            increased classical mesenchymal subtypes (Figure 6F), associated <br />                                                            poor overall progression-free survival (Verhaak et al., 2010). EEF2K expression <br />                                                            strongly correlated decreased overall survival human glioma subtypes <br />                                                            (astrocytoma, oligodendroglioma, mixed glioma, GBM) (p = 0.0001; Figure 6G),                                                            GBM itself (p = 0.001; Figure 6H).  findings highlight eEF2K <br />                                                            expression prognostic biomarker aggressive human brain tumors. <br />  <br />                                                            evaluated eEF2K activity MB tumor samples IHC phospho-eEF2.                                                            mouse model MB (Wu et al., 2012), primary tumors (Figure 6I, panels 1 2)                                                            matching metastases (Figure 6I, panels 3 4) showed extensive tumor-specific eEF2 <br />                                                            phosphorylation  e., inactivation), adjacent normal cerebellar tissue negative. <br />                                                            Similar findings observed primary human MB tumors (n = 7) (Figure 6J).  <br />                                                            eEF2K activity strongly induced MB tissues, primary tumor metastatic <br />                                                            compartments, compared normal cerebellar tissue. Finally, tested potential <br />                                                            involvement eEF2K response MB cells ND. group 3 human MB d283 <br />                                                            cell line highly resistant ND (Figures S7A S7B).  d283 cells transfected <br />                                                            eEF2K siRNAs exhibited significantly higher cell death ND compared                                                            controls (Figures 6K S7C). suggests eEF2K promotes survival MB <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            cells ND.  findings indicate eEF2K expression predictive                                                            outcome MB GBM eEF2K activity protects MB cells ND. <br />  <br />                                             eEF2K Ortholog efk-1 Critical Survival C. elegans ND <br />                                                            test protective role eEF2K conserved, examined physiological <br />                                                            responses ND vivo using nematode worm Caenorhabditis elegans. absence <br />                                                            nutrients, newly hatched larval stage (L1) C. elegans worms enter dormant state <br />                                                            termed &#226;&#8364;&#339;L1 diapause,&#226;&#8364;? development halted survival sustained 2 3 <br />                                                            weeks (Johnson et al., 1984), providing useful model study survival mechanisms <br />                                                            ND independently concomitant developmental programs. assessed deletion <br />                                                            allele C. elegans eEF2K ortholog, efk-1(ok3609), survival starved L1 larvae                                                            determine conserved role efk-1 managing ND. deletion <br />                                                            efk-1 minor effect lifespans animals grown nutrient-rich <br />                                                            conditions, survival efk-1(ok3609) substantially reduced ND compared                                                            wild-type (wt) (N2) worms (Figures 7A 7B).  mean lifespan N2 animals                                                            absence nutrients 13.1 days, efk-1 mutant worms mean lifespan                                                            7.4 days (p &lt; 0.00058; Figure 7B).  efk-1 transcripts markedly induced <br />                                                            ND wt L1 larvae (Figure 7C), eEF2K levels various mouse human <br />  <br />  <br />                                                                     Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                           Page 10 <br />  <br />  <br />                                                            cell lines subjected ND (Figure 7D). findings provide compelling evidence                                                            eEF2K ortholog efk-1 component physiological response C. elegans ND  <br />                                                             role eEF2K pathway highly conserved. <br />  <br />  <br />                                             DISCUSSION <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                             efk-1/eEF2K Component Stress Response ND <br />                                                            Nutrient deprivation activates multiple transcriptional cascades reprogram metabolism <br />                                                            nutrients limited, induction AMPK subunit &#206;&#177;-2 (prkaa-2/aak-2) (Baugh <br />                                                            et al., 2009; Jagoe et al., 2002).  report mammalian eEF2K C. elegans <br />                                                            ortholog efk-1 ND-responsive genes components nutrient stress adaptive <br />                                                            program. mice, eEF2K expression upregulated neonates deprived                                                            transplacental nutrient supply (Sakagami et al., 2002). findings, suggests <br />                                                            efk-1/eEF2K evolved preserve cell survival                                                            physiological ND (Figure 7E). Given eEF2K blocks mRNA translation elongation,                                                            reflect need block translation elongation initiation optimal <br />                                                            adaptive response.  4EBP1 expression increases ND (Jagoe et al., 2002)                                                            support adaptation metabolic stress, including ND hypoxia (Braunstein et al., 2007; <br />                                                            Teleman et al., 2005). <br />  <br />                                             eEF2K Blocks Translation Elongation Protect Cells ND <br />                                                            Inhibiting global mRNA translation increases resistance ND vivo (Pan et al., 2007; <br />                                                            Teleman et al., 2005).  mTORC1 inactivated ND preserve energy balance <br />                                                            amino acids (Choo et al., 2010; Teleman et al., 2005). findings suggest                                                            mTORC1 inhibition insufficient fully protect cells ND eEF2K <br />                                                            activation critical. relies inhibition eEF2K substrate, eEF2, <br />                                                            supporting notion translation initiation elongation inhibited Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            promote survival (Figure 7E). Unexpectedly, inhibition translation elongation                                                            linked preservation ATP altered ROS autophagic flux.  inhibition <br />                                                            elongation did affect global protein synthesis rates nutrient-deprived cells,                                                            overall protein synthesis strongly reduced block translation <br />                                                            initiation.  eEF2K activation does appear promote stalling ribosomes                                                            transcripts, secondary blocked translation elongation. suggests  absence                                                            eEF2K activation, polypeptides elongate ND transcripts                                                            bypass block initiation alternative initiation mechanisms (cap-independent                                                            uORF-based processes), supporting continued translation nutrient stress. <br />                                                             eEF2K block synthesis specific subgroups proteins instead affecting <br />                                                            overall synthesis. particularly relevant include proapoptotic factors                                                            anabolic drivers inhibition critical adaptation ND. keeping                                                            notion, 4E-BP, protective ND (Teleman et al., 2005), blocks synthesis                                                            specific subsets proteins involved proliferation polyamine biosynthesis (Dowling <br />                                                            et al., 2010). <br />  <br />  <br />  <br />  <br />                                                                     Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                           Page 11 <br />  <br />  <br />                                             eEF2K Hijacked Tumor Cells Adaptation ND <br />                                                            tumor development, transformed cells adapt metabolic stress ND <br />                                                            anabolic processes typically driven oncogenic pathways deleterious <br />                                                            effects cell nutrients scarce (Jones Thompson, 2009). vitro <br />                                                            studies indicate hypersensitivity RasV12- transformed cells ND                                                            block eEF2K activation combination sustained Ras-Erk-p90RSK signaling <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            dampened AMPK induction. Given Ras-Erk pathway overactive ~25%                                                            human tumors, eEF2K inhibited diverse tumors, restricting                                                            capacity survive nutrients limited.  observed RasV12-  <br />                                                            transformed cells adapt nutrient stress, sustained Ras-Erk activity.                                                            agreement previous studies reporting  oncogenic Ras primarily <br />                                                            sensitizes fibroblasts reduced nutrients (Chiaradonna et al., 2006), support <br />                                                            adaptation ND increasing Glut1 glucose uptake tumor cells (Yun et al., 2009). <br />                                                            propose additional mechanism adaptation reactivation AMPK- <br />                                                            eEF2K axis occurs ability cells, unexpectedly, raise AMP:ATP                                                            ADP:ATP ratios. contrast, defective AMPK activation nonadapted cells results                                                            sustained ATP levels, blocking increase AMP:ATP ADP:ATP ratios.                                                            suggests nonadapted tumor cells maintain specific anabolic processes ND <br />                                                            sustain ATP. <br />  <br />                                                            tempting speculate eEF2K-mediated adaptation ND mimics process <br />                                                            occurring primary tumors subjected repeated cycles metabolic stress.                                                            mechanism ND-induced eEF2K activation vitro appears involve,  <br />                                                            activation AMPK-eEF2K pathway modulation cellular AMP:ATP                                                            ADP:ATP ratios. vivo, defects eEF2K activity rendered tumor xenografts sensitive                                                            CR reported models (Kalaany Sabatini, 2009). reduction                                                            glucose levels CR modest compared severe conditions imposed vitro, Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            suggests eEF2K-deficient tumors sensitive moderate reductions                                                            glucose vivo. addition, major effect CR reduce plasma levels insulin                                                            IGF1 (Kalaany Sabatini, 2009). eEF2K negatively regulated factors <br />                                                            (Wang et al., 2001), vivo necrosis eEF2K-deficient tumors CR reflect <br />                                                            enhanced sensitivity tumors decreased plasma levels insulin IGF1. speculate <br />                                                            combined effect compromised plasma nutrient availability, including modestly <br />                                                            reduced glucose levels, coupled decreased insulin IGF1 levels, collaborate                                                            render eEF2K-deficient tumors sensitive CR. <br />  <br />                                                            summary, data reinforce importance AMPK management nutrient stress <br />                                                            tumors, AMPK supports adaptation ND activating eEF2K blocking <br />                                                            translation elongation, addition inhibiting ACC fatty acid synthesis reported <br />                                                            (Jeon et al., 2012).  eEF2K emerges critical prosurvival factor                                                            exploited tumors support adaptation metabolic stress. development                                                            therapeutic strategies target eEF2K kinase tumors, especially aggressive human <br />                                                            brain tumors, warrants investigation. strategies particularly relevant                                                            combined CR mimetics 2-DG, angiogenesis inhibitors, resveratrol, eEF2K <br />                                                            selectively protect tumors CR nonstress conditions.  <br />  <br />                                                                     Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                                              Page 12 <br />  <br />  <br />                                                            conclusion, inhibition mRNA translation elongation represents important mechanism <br />                                                            tumor cells adapt ND, highlighting previously unrecognized possibilities                                                            therapeutic targeting metabolically adapted tumor cells. <br />  <br />  <br />                                             EXPERIMENTAL PROCEDURES <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                             Cell Culture Xenografts <br />                                                            NIH 3T3, MG63, HeLa, d283 cells purchased ATCC. NIH 3T3 cells stably <br />                                                            expressing K-RasV12 described (Ng et al., 2012). Immortalized WT                                                            eEF2K-deficient MEFs gifts Dr. Alexey Ryazanov (University Medicine                                                            Dentistry New Jersey). ND performed ~50% subconfluent cultures Hanks <br />                                                            buffered saline solution (HBSS)-HEPES (CaCl2&#194;&#183;2H2O, 0.185 g/l; MgSO4&#194;&#183;7H2O, 0.2 g/l; <br />                                                            KCl, 0.4 g/l; KH2PO4 [anhydrous], 0.06 g/l; NaHCO3, 0.35 g/l; NaCl, 8 g/l; <br />                                                            Na2HPO4&#194;&#183;7H2O, 0.09 g/l; 20 mM HEPES, pH 7.4) containing glucose,                                                            indicated times, resupplemented glucose (4.5 g/l; Fisher) 1&#195;&#8212; MEM essential <br />                                                            nonessential amino acid solutions (Invitrogen) glutamine (2 mM; Invitrogen)                                                            indicated. tumor xenografts, cells injected subcutaneously (5 &#195;&#8212; 105 cells site) <br />                                                            flanks nu/nu mice (Harlan Laboratories). CR experiments carried                                                            described (Kalaany Sabatini, 2009); mice CR group received 60% daily <br />                                                            food intake ad libitum counterparts. days postinjection, tumor tissues                                                            snap frozen liquid N2 formalin fixed IHC. <br />  <br />                                             Protein Synthesis Rate <br />                                                            [35S]-methionine-cysteine incorporation, cells pulse labeled 10 &#206;&#188;Ci [35S]- <br />                                                            methionine cysteine mix ml (EasyTag EXPRESS, Perkin Elmer) 5 min HBSS- <br />                                                            HEPES described (Ng et al., 2012). AHA incorporation assays, cells incubated <br />                                                            methionine-free DMEM containing 10% CS 1 hr pulse labeled 50 &#206;&#188;M L- <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            AHA 45 min methionine-free DMEM containing 10% CS HBSS-HEPES. Cells <br />                                                            processed described Somasekharan et al. (2012) fixed, permeabilized, <br />                                                            labeled using Click Cell Reaction Buffer Kit (Invitrogen) Alexa Fluor 488 <br />                                                            azide probe (Invitrogen) sorted FACS (BD Bioscience). <br />  <br />                                             C. elegans Studies <br />                                                            C. elegans strains cultured 20&#194;&#176;C nematode growth media (NGM) plates using <br />                                                            standard protocols (Brenner, 1974). WT Bristol N2 strain worms efk-1(ok3609) deletion <br />                                                            mutants obtained Caenorhabditis Genetics Centre (CGC) National <br />                                                            Institutes Health Center Research Resources. <br />  <br />  <br />                                             Supplementary Material <br />                                                            Refer Web version PubMed Central supplementary material. <br />  <br />  <br />                                             ACKNOWLEDGMENTS <br />                                                            thank T. Tang, M. Robertson, C. Chow technical assistance B. Fonseca (McGill University), S. <br />                                                            Aparicio, S. Mullaly, T. Ng (UBC), J  Pospisilik, R. Teperino (Max Planck Institute, Freiburg) helpful <br />  <br />  <br />  <br />                                                                       Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                                           Page 13 <br />  <br />                                                            discussions. work supported Canadian Cancer Society Research Institute British Columbia <br />                                                            Cancer Foundation  P.H.S.) generous donations Team Finn riders Ride Conquer <br />                                                            Cancer National Institutes Health (CA159859), Terry Fox Research Institute, Pediatric <br />                                                            Brain Tumor Foundation  M.D.T.). <br />  <br />  <br />                                             REFERENCES <br />                                                            Baugh LR, Demodena J, Sternberg PW. RNA Pol II accumulates promoters growth genes Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                               developmental arrest. Science. 2009; 324:92&#226;&#8364;&#8220;94. [PubMed: 19251593] <br />                                                            Braunstein S, Karpisheva K, Pola C, Goldberg J, Hochman T, Yee H, Cangiarella J, Arju R, Formenti <br />                                                               SC, Schneider RJ. hypoxia-controlled cap-dependent cap-independent translation switch                                                               breast cancer. Mol. Cell. 2007; 28:501&#226;&#8364;&#8220;512. [PubMed: 17996713] <br />                                                            Brenner S. genetics Caenorhabditis elegans. Genetics. 1974; 77:71&#226;&#8364;&#8220;94. [PubMed: 4366476] <br />                                                            Buttgereit F, Brand MD. hierarchy ATP-consuming processes mammalian cells. Biochem. J. <br />                                                               1995; 312:163&#226;&#8364;&#8220;167. [PubMed: 7492307] <br />                                                            Buzzai M, Bauer  Jones RG, Deberardinis RJ, Hatzivassiliou G, Elstrom RL, Thompson CB.                                                               glucose dependence Akt-transformed cells reversed pharmacologic activation fatty <br />                                                               acid beta-oxidation. Oncogene. 2005; 24:4165&#226;&#8364;&#8220;4173. [PubMed: 15806154] <br />                                                            Carlberg U, Nilsson  Nyg&#195;&#165;rd O. Functional properties phosphorylated elongation factor 2. Eur. J. <br />                                                               Biochem. 1990; 191:639&#226;&#8364;&#8220;645. [PubMed: 2390990] <br />                                                            Caro-Maldonado  Mu&#195;&#177;oz-Pinedo C. Dying eat: cells respond starvation. <br />                                                               Open Cell Signaling Journal. 2011; 3:42&#226;&#8364;&#8220;51. <br />                                                            Chiaradonna F, Sacco E, Manzoni R, Giorgio M, Vanoni M, Alberghina L. Ras-dependent carbon <br />                                                               metabolism transformation mouse fibroblasts. Oncogene. 2006; 25:5391&#226;&#8364;&#8220;5404. [PubMed: <br />                                                               16607279] <br />                                                            Choo AY, Kim SG, Vander Heiden MG, Mahoney SJ, Vu H, Yoon  Cantley LC, Blenis J. Glucose <br />                                                               addiction TSC null cells caused failed mTORC1-dependent balancing metabolic demand <br />                                                               supply. Mol. Cell. 2010; 38:487&#226;&#8364;&#8220;499. [PubMed: 20513425] <br />                                                            Dowling RJ, Topisirovic  Alain T, Bidinosti M, Fonseca BD, Petroulakis E, Wang X, Larsson O, <br />                                                                Selvaraj  Liu Y, et al. mTORC1-mediated cell proliferation, cell growth, controlled                                                                4E-BPs. Science. 2010; 328:1172&#226;&#8364;&#8220;1176. [PubMed: 20508131] <br />                                                            Fan H, Penman S. Regulation protein synthesis mammalian cells. II. Inhibition protein <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                                synthesis level initiation mitosis. J. Mol. Biol. 1970; 50:655&#226;&#8364;&#8220;670. [PubMed: <br />                                                                5529301] <br />                                                            Hardie DG. AMP-activated protein kinase: energy sensor regulates aspects cell function. <br />                                                                Genes Dev. 2011; 25:1895&#226;&#8364;&#8220;1908. [PubMed: 21937710] <br />                                                            Hay N, Sonenberg N. Upstream downstream mTOR. Genes Dev. 2004; 18:1926&#226;&#8364;&#8220;1945. <br />                                                                [PubMed: 15314020] <br />                                                            Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response control cell growth survival. <br />                                                                Cell. 2003; 115:577&#226;&#8364;&#8220;590. [PubMed: 14651849] <br />                                                            Jagoe RT, Lecker SH, Gomes M, Goldberg AL. Patterns gene expression atrophying skeletal <br />                                                                muscles: response food deprivation. FASEB J. 2002; 16:1697&#226;&#8364;&#8220;1712. [PubMed: 12409312] <br />                                                            Jeon SM, Chandel NS, Hay N. AMPK regulates <span id='am-23' about='obo:IMR_0200463' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-24' property="oboInOwl:hasDbXref" content="KEGG:C00005" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:id" content="IMR:0200463" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="NADPH" datatype="xsd:string"></span>NADPH</span> homeostasis promote tumour cell survival <br />                                                                energy stress. Nature. 2012; 485:661&#226;&#8364;&#8220;665. [PubMed: 22660331] <br />                                                            Johnson TE, Mitchell DH, Kline S, Kemal R, Foy J. Arresting development arrests aging                                                                nematode Caenorhabditis elegans. Mech. Ageing Dev. 1984; 28:23&#226;&#8364;&#8220;40. [PubMed: 6542614] <br />                                                            Jones RG, Thompson CB. Tumor suppressors cell metabolism: recipe cancer growth. Genes <br />                                                                Dev. 2009; 23:537&#226;&#8364;&#8220;548. [PubMed: 19270154] <br />                                                            Kalaany NY, Sabatini DM. Tumours PI3K activation resistant dietary restriction. Nature. <br />                                                                2009; 458:725&#226;&#8364;&#8220;731. [PubMed: 19279572] <br />                                                            Knezevich SR, McFadden  Tao W, Lim JF, Sorensen PH. novel ETV6-NTRK3 gene fusion                                                                congenital fibrosarcoma. Nat. Genet. 1998; 18:184&#226;&#8364;&#8220;187. [PubMed: 9462753] <br />                                                            Liang J, Shao SH, Xu ZX, Hennessy B, Ding  Larrea M, Kondo S, Dumont DJ, Gutterman JU, <br />                                                                Walker CL, et al. energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation <br />  <br />  <br />                                                                      Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                                  Page 14 <br />  <br />  <br />                                                                mediating decision enter autophagy apoptosis. Nat. Cell Biol. 2007; 9:218&#226;&#8364;&#8220;224. <br />                                                                [PubMed: 17237771] <br />                                                            Mathews, MB.; Sonenberg, N.; Hershey, JWB. Origin principles translational control.  <br />                                                                Mathews, MB.; Sonenberg, N.; Hershey, JWB., editors. Translational Control Biology                                                                Medicine. Cold Spring Harbor Laboratory Press; Cold Spring Harbor, NY: 2007. p. 1-40. <br />                                                            Mauro C, Leow SC, Anso E, Rocha S, Thotakura AK, Tornatore L, Moretti M, Smaele E, Beg AA, <br />                                                                Tergaonkar V, et al. NF-&#206;&#186;B controls energy homeostasis metabolic adaptation upregulating <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                                mitochondrial respiration. Nat. Cell Biol. 2011; 13:1272&#226;&#8364;&#8220;1279. [PubMed: 21968997] <br />                                                            Nagy JA, Chang SH, Dvorak  Dvorak HF. tumour blood vessels abnormal                                                                important know? Br. J. Cancer. 2009; 100:865&#226;&#8364;&#8220;869. [PubMed: 19240721] <br />                                                            Ng TL, Leprivier G, Robertson MD, Chow C, Martin MJ, Laderoute KR, Davicioni E, Triche TJ, <br />                                                                Sorensen PH. AMPK stress response pathway mediates anoikis resistance inhibition <br />                                                                mTOR suppression protein synthesis. Cell Death Differ. 2012; 19:501&#226;&#8364;&#8220;510. [PubMed: <br />                                                                21941369] <br />                                                            Northcott PA, Korshunov  Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, <br />                                                                Hawkins CE, French P, et al. Medulloblastoma comprises distinct molecular variants. J. Clin. <br />                                                                Oncol. 2011; 29:1408&#226;&#8364;&#8220;1414. [PubMed: 20823417] <br />                                                            Pan KZ, Palter JE, Rogers  Olsen  Chen D, Lithgow GJ, Kapahi P. Inhibition mRNA <br />                                                                translation extends lifespan Caenorhabditis elegans. Aging Cell. 2007; 6:111&#226;&#8364;&#8220;119. [PubMed: <br />                                                                17266680] <br />                                                            Proud CG. Signalling translation: signal transduction pathways control protein synthetic <br />                                                                machinery. Biochem. J. 2007; 403:217&#226;&#8364;&#8220;234. [PubMed: 17376031] <br />                                                            Ryazanov AG, Shestakova EA, Natapov PG. Phosphorylation elongation factor 2 EF-2 kinase <br />                                                                affects rate translation. Nature. 1988; 334:170&#226;&#8364;&#8220;173. [PubMed: 3386756] <br />                                                            Sakagami H, Nishimura H, Saito R, Kondo H. Transient upregulation elongation factor-2 kinase <br />                                                                (Ca2+/calmodulin-dependent protein kinase III) messenger RNA developing mouse brain. <br />                                                                Neurosci. Lett. 2002; 330:41&#226;&#8364;&#8220;44. [PubMed: 12213630] <br />                                                            Shim H, Chun YS, Lewis BC, Dang CV. unique glucose-dependent apoptotic pathway induced                                                                c-Myc. Proc. Natl. Acad. Sci. USA. 1998; 95:1511&#226;&#8364;&#8220;1516. [PubMed: 9465046] <br />                                                            Somasekharan SP, Stoynov N, Rotblat B, Leprivier G, Galpin JD, Ahern CA, Foster LJ, Sorensen PH. <br />                                                                Identification quantification newly synthesized proteins translationally regulated YB-1 <br />                                                                using novel Click-SILAC approach. J. Proteomics. 2012; 77:e1&#226;&#8364;&#8220;e10. [PubMed: 22967496] <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            Teleman AA, Chen YW, Cohen SM. 4E-BP functions metabolic brake used stress <br />                                                                conditions normal growth. Genes Dev. 2005; 19:1844&#226;&#8364;&#8220;1848. [PubMed: 16103212] <br />                                                            Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, <br />                                                                MacPherson N, Horsman D, et al. Expression ETV6-NTRK3 gene fusion primary event <br />                                                                human secretory breast carcinoma. Cancer Cell. 2002; 2:367&#226;&#8364;&#8220;376. [PubMed: 12450792] <br />                                                            Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, <br />                                                                Mesirov JP, et al. Cancer Genome Atlas Research Network. Integrated genomic analysis identifies <br />                                                                clinically relevant subtypes glioblastoma characterized abnormalities PDGFRA, IDH1, <br />                                                                EGFR, NF1. Cancer Cell. 2010; 17:98&#226;&#8364;&#8220;110. [PubMed: 20129251] <br />                                                            Wang X, Li W, Williams M, Terada N, Alessi DR, Proud CG. Regulation elongation factor 2 kinase <br />                                                                p90(RSK1) p70 S6 kinase. EMBO J. 2001; 20:4370&#226;&#8364;&#8220;4379. [PubMed: 11500364] <br />                                                            Wu H, Yang JM, Jin S, Zhang H, Hait WN. Elongation factor-2 kinase regulates autophagy human <br />                                                                glioblastoma cells. Cancer Res. 2006; 66:3015&#226;&#8364;&#8220;3023. [PubMed: 16540650] <br />                                                            Wu X, Northcott PA, Dubuc  Dupuy AJ, Shih DJ, Witt H, Croul S, Bouffet E, Fults DW, Eberhart <br />                                                                CG, et al. Clonal selection drives genetic divergence metastatic medulloblastoma. Nature. 2012; <br />                                                                482:529&#226;&#8364;&#8220;533. [PubMed: 22343890] <br />                                                            Ye J, Kumanova M, Hart LS, Sloane K, Zhang H, Panis DN, Bobrovnikova-Marjon E, Diehl JA, <br />                                                                Ron D, Koumenis C. GCN2-ATF4 pathway critical tumour cell survival                                                                proliferation response nutrient deprivation. EMBO J. 2010; 29:2082&#226;&#8364;&#8220;2096. [PubMed: <br />                                                                20473272] <br />  <br />  <br />  <br />  <br />                                                                     Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                             Page 15 <br />  <br />  <br />                                                            Yun J, Rago C, Cheong  Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Willson JK, <br />                                                               Markowitz S, Zhou S, et al. Glucose deprivation contributes development KRAS pathway <br />                                                               mutations tumor cells. Science. 2009; 325:1555&#226;&#8364;&#8220;1559. [PubMed: 19661383] <br />                                                            Zaugg K, Yao Y, Reilly PT, Kannan K, Kiarash R, Mason J, Huang P, Sawyer SK, Fuerth B, Faubert <br />                                                               B, et al. <span id='am-44' about='obo:IMR_0200035' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-45' property="rdfs:label" content="Carnitine" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:id" content="IMR:0200035" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-48' property="oboInOwl:hasDbXref" content="KEGG:C00487" datatype="xsd:string"></span>Carnitine</span> palmitoyltransferase 1C promotes cell survival tumor growth                                                               conditions metabolic stress. Genes Dev. 2011; 25:1041&#226;&#8364;&#8220;1051. [PubMed: 21576264] <br />                                                            Zoncu R, Efeyan  Sabatini DM. mTOR: growth signal integration cancer, diabetes Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                               ageing. Nat. Rev. Mol. Cell Biol. 2011; 12:21&#226;&#8364;&#8220;35. [PubMed: 21157483] <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                                     Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                         Page 16 <br /> Europe PMC Funders Author Manuscripts <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            Figure 1. Oncogenic Transformation Sensitizes Cells ND Alters eEF2 Signaling Pathways <br />                                                              Caspase-3 activity assays NIH 3T3 MSCV,  RasV12 cells grown complete <br />                                                            media deprived nutrients (ND) indicated times (n = 3). <br />                                                            (B) Schematic representation nutrient-responsive signaling pathways assessed                                                            study. Gray arrows bars indicate release regulatory effects upstream pathways. <br />                                                            (C) Immunoblot analysis NIH 3T3 MSCV,  RasV12 cells grown complete <br />                                                            media ND indicated times. <br />  <br />  <br />  <br />  <br />                                                                    Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                      Page 17 <br />  <br />  <br />                                                            (D) Intracellular levels AMP ATP NIH 3T3 MSCV,  RasV12, S,                                                            RasV12-S cells grown complete media (Ctrl) ND 6 hr. Results expressed <br />                                                            relative fold increases AMP:ATP ratio MSCV Ctrl n = 3. <br />                                                            (E) Immunoblot analysis NIH 3T3 RasV12 cells deprived nutrients (1 hr)                                                            treated Akt inhibitor VII (Akti; 1 &#206;&#188;M), rotenone (0.5 &#206;&#188;M), 2-deoxyglucose (2-DG; 25 <br />                                                            mM), vehicle. <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            (F) Scheme generation S RasV12-S cells NIH 3T3 RasV12 cells <br />                                                             . Caspase-3 activity assays NIH 3T3  S, RasV12, RasV12-S cells grown                                                            complete media ND indicated (n = 3)  . <br />                                                            (G) Immunoblot analysis NIH 3T3  S, RasV12, RasV12-S cells grown                                                            complete media ND indicated times. <br />                                                            (H) Immunoblot analysis NIH 3T3 S/MSCV, S/DN-AMPK, RasV12-S/MSCV, <br />                                                            RasV12-S/DN-AMPK cells grown complete media ND indicated <br />                                                            times. <br />                                                              Caspase-3 assays NIH 3T3 S/MSCV, S/DN-AMPK, RasV12-S/MSCV,                                                            RasV12-S/DN-AMPK cells grown complete media (Ctrl) ND 48 hr (n = 3). <br />                                                            shown, data reported means &#194;&#177; SD indicated significance (*p &lt; 0.05, **p <br />                                                            &lt; 0.01, ***p &lt; 0.005). Figures S1 S2. <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                                    Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                          Page 18 <br /> Europe PMC Funders Author Manuscripts <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            Figure 2. Translation Elongation Activity Sustained Transformed Cells ND                                                            Reduces Survival <br />                                                              Protein synthesis levels NIH 3T3 MSCV,  RasV12 cells deprived nutrients <br />                                                            5 min 1, 3, 6 hr determined [35S]-methionine/cysteine(Met/Cys) incorporation. <br />                                                            Results expressed percentage [35S]-Met/Cys incorporation/mg protein relative                                                            MSCV cells 5 min (n = 2). <br />                                                            (B) Polysome profiles NIH 3T3 MSCV,  RasV12 cells grown complete media <br />                                                            ND 70 min described Extended Experimental Procedures. P/S indicates <br />                                                            ratio polysomal subpolysomal (40S, 60S, 80S) fractions. <br />  <br />                                                                    Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                        Page 19 <br />  <br />  <br />                                                            (C) Ribosome half-transit times NIH 3T3 MSCV,  RasV12 cells grown                                                            complete media ND 70 min. [35S]-Met/Cys incorporation polypeptides <br />                                                            (postmitochondrial supernatant, PMS) polypeptides released ribosomes <br />                                                            (postribosomal supernatant, PRS) obtained linear regression analysis. Representative <br />                                                            results different experiments shown. <br />                                                            (D E) siRNA-mediated knockdown eEF2 NIH 3T3 RasV12 cells. Cells <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            transiently transfected 12.5 nM control (CTRL) eEF2-directed siRNAs, <br />                                                            grown complete media 48 hr, placed ND 48 hr. Lysates                                                            analyzed immunoblotting (D) assayed caspase-3 activity (n = 3) (E). <br />                                                            (F G) siRNA-mediated knockdown eEF2 NIH 3T3 S/MSCV, S/DN- <br />                                                            AMPK, RasV12-S/MSCV, RasV12-S/DN-AMPK cells. Cells transfected, treated, <br />                                                            analyzed (D) (E). <br />                                                            shown, data reported means &#194;&#177; SD indicated significance (**p &lt; 0.005). <br />                                                            Figure S3. <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                                    Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                   Page 20 <br /> Europe PMC Funders Author Manuscripts <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            Figure 3. eEF2K Critical Adaptation Fibroblasts ND <br />                                                              Caspase-3 activity assays eEF2K+/+ eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217; MEFs grown complete media <br />                                                            ND indicated times (n = 3). <br />                                                            (B C) siRNA-mediated knockdown eEF2 eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217; MEFs. Cells transiently <br />                                                            transfected 12.5 nM control (CTRL) eEF2-directed siRNAs, grown complete <br />                                                            media 48 hr, placed ND 48 hr. Cell lysates analyzed                                                            immunoblotting (B) assayed caspase-3 activity (n = 3) (C). <br />  <br />  <br />  <br />  <br />                                                                     Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                      Page 21 <br />  <br />  <br />                                                            (D E) siRNA-mediated knockdown eEF2K eEF2 NIH 3T3 MSCV cells                                                            transient transfection 37.5 nM control (siCTRL) 25 nM eEF2K siRNAs (si <br />                                                            eEF2K#1 eEF2K#2) combined 12.5 nM control eEF2 siRNAs. Cells                                                            treated described (B) (C). Lysates analyzed immunoblotting (D)                                                            assayed cell death (n = 3) (E). <br />                                                            (F) Immunoblot analysis NIH 3T3 MSCV, eEF2K, RasV12/MSCV, RasV12/ <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            eEF2K grown complete media ND indicated times. <br />                                                            (G) Caspase-3 activity assays NIH 3T3 MSCV, eEF2K, eEF2K-K170M <br />                                                            (kinase-dead), RasV12/MSCV, RasV12/eEF2K, RasV12/eEF2K-K170M cells grown                                                            complete media (Ctrl) ND 48 hr (n = 3). <br />                                                            (H  siRNA-mediated knockdown eEF2K NIH 3T3 S RasV12-S cells. <br />                                                            Cells transiently transfected 25 nM control (siCTRL) eEF2K (si eEF2K#1 <br />                                                            eEF2K#2) siRNAs grown complete media 72 hr. Cells placed ND <br />                                                            3 hr analyzed immunoblotting (H) 72 hr assayed caspase-3 <br />                                                            activity (n = 3)  . <br />                                                            (J) Cell adaptation assays eEF2K+/+ eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217; MEFs expressing RasV12. <br />                                                            Cells subjected adaptation protocol described Extended Experimental <br />                                                            Procedures. Results expressed number cells alive completion                                                            experiment (n = 3). <br />                                                            shown, data reported means &#194;&#177; SD indicated significance (*p &lt; 0.05                                                            **p &lt; 0.01; ns, nonsignificant). Figure S4. <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                                    Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                      Page 22 <br /> Europe PMC Funders Author Manuscripts <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            Figure 4. eEF2K Facilitates Survival Human Tumor Cells Response ND <br />                                                              Immunoblot analysis HeLa MG63 cells grown complete media ND <br />                                                            indicated times. <br />                                                            (B C) Caspase-3 activity assays (B) cell death assays (C) HeLa MG63 cells <br />                                                            grown complete media ND indicated times (n = 3). <br />                                                            (D E) siRNA-mediated knockdown eEF2 HeLa cells. Cells transiently <br />                                                            transfected 12.5 nM control (CTRL) eEF2-directed siRNAs, grown complete <br />                                                            media 48 hr, placed ND 48 hr. Cell lysates analyzed                                                            immunoblotting (D) assayed caspase-3 activity (n = 3) (E). <br />                                                            (F G) Immunoblot analysis (F) caspase-3 activity assays (n = 3) (G) HeLa MSCV <br />                                                            HeLa eEF2K cells grown complete media ND indicated times. <br />  <br />  <br />  <br />                                                                    Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                       Page 23 <br />  <br />  <br />                                                            (H  siRNA-mediated knockdown eEF2K MG63 cells. Cells transiently <br />                                                            transfected 25 nM control (siCTRL) eEF2K (si eEF2K#1&#226;&#8364;&#178; eEF2K#2&#226;&#8364;&#178;) siRNAs <br />                                                            grown complete media 72 hr. Cells placed ND 3 hr                                                            analyzed immunoblotting (H) 72 hr assayed caspase-3 activity (n = 3)  . <br />                                                            shown, data reported means &#194;&#177; SD indicated significance (*p &lt; 0.05, **p <br />                                                            &lt; 0.01, ***p &lt; 0.005). Figure S5. <br /> Europe PMC Funders Author Manuscripts <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                                    Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                         Page 24 <br /> Europe PMC Funders Author Manuscripts <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            Figure 5. eEF2K Promotes Resistance Tumors Caloric Restriction-Induced Cell Death                                                            Vivo <br />                                                             B) Tumor volumes NIH 3T3 RasV12/MSCV RasV12/eEF2K   MSCV <br />                                                            eEF2K (B) xenografts implanted subcutaneously nu/nu mice. Mice fed <br />                                                            AL placed CR diets (n = 10 mice/group). <br />                                                            (C) Hematoxylin eosin staining (H&amp;E) tumor xenografts  . Black arrows <br />                                                            indicate regions necrosis. Results expressed percentages necrotic/total tumor <br />                                                            areas (n = 3 mice group). <br />  <br />  <br />  <br />                                                                    Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                            Page 25 <br />  <br />  <br />                                                            (D) Immunohistochemical (IHC) staining tumor xenografts   antibodies <br />                                                            cleaved caspase-3. Graphs indicate percent total cells positive cleaved <br />                                                            caspase-3 (n = 3 mice group). <br />                                                            (E) IHC staining tumor xenografts   anti-phospho-eEF2 antibodies. <br />                                                            (F) Immunoblot analysis tumor lysates tumor xenografts  . <br />                                                            (G) Tumor volumes eEF2K+/+ RasV12 eEF2K&#226;&#710;&#8217;/&#226;&#710;&#8217; RasV12 xenografts implanted <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            subcutaneously nu/nu mice. Mice fed AL placed CR diets (n = 10 mice <br />                                                            group). <br />                                                            (H) H&amp;E staining tumor xenografts (G). Black arrows indicate areas necrosis. <br />                                                            Results expressed percentages necrotic/total tumor areas (n = 3 mice group). <br />                                                              IHC staining tumor xenografts (G) antibodies cleaved caspase-3. Graphs <br />                                                            indicate percent total cells positive cleaved caspase-3 (n = 3 mice group). <br />                                                            shown, data reported means &#194;&#177; SEM indicated significance (*p &lt; 0.05                                                            **p &lt; 0.01; ns, nonsignificant). Figure S6. <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                                     Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                        Page 26 <br /> Europe PMC Funders Author Manuscripts <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            Figure 6. eEF2K Transcript Levels Associated Poor Prognosis Medulloblastoma                                                            Glioblastoma Multiforme <br />                                                             B) Expression levels eEF2K Toronto MB cohort   European MB <br />                                                            data set (B)  Extended Experimental Procedures). FC CB indicate fetal adult <br />                                                            cerebellum, respectively; MBs indicate total cohort, WNT, SHH, group 3, group <br />                                                            4 indicate specific disease subgroups. p values shown panel                                                            generated using Mann-Whitney U test. <br />                                                            (C D) Kaplan-Meier estimates overall survival MB patients subgroups <br />                                                            (C) non-WNT/non-SHH subgroups (D) classified eEF2K mRNA expression <br />  <br />                                                                    Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                           Page 27 <br />  <br />  <br />                                                            levels. number patients risk indicated time increments 24 months. p values <br />                                                            calculated using log rank test. <br />                                                            (E F) Expression eEF2K mRNA normal human brain (NHB; n = 10) compared                                                            GBM (n = 25) (E) specific disease subtypes GBM (proneural, neural, classical,                                                            mesenchymal) (F). p values determined ANOVA Bonferroni post hoc test. <br />                                                            (G H) Kaplan-Meier estimates overall survival glioma patients (G) GBM <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            patients (H) classified eEF2K mRNA expression levels. Survival indicated time <br />                                                            increments 2,000 (G) 500 days (H). p values calculated using log rank test. <br />                                                             J) IHC staining phospho-eEF2 primary tumors   1&#226;&#8364;&#8220;2) corresponding <br />                                                            metastases   3&#226;&#8364;&#8220;4) mouse model MB (Wu et al., 2012) human primary MB <br />                                                            (J). Black arrows indicate tumor regions, white triangles indicate adjacent normal <br />                                                            cerebellar tissue. <br />                                                            (K) siRNA-mediated knockdown eEF2K d283 MB cells. Cells transiently <br />                                                            transfected 25 nM control (siCTRL) eEF2K siRNAs (si eEF2K#1&#226;&#8364;&#178;                                                            eEF2K#2&#226;&#8364;&#178;), grown complete media 72 hr, harvested placed ND 24 hr. <br />                                                            Cell lysates assayed caspase-3 activity. Error bars indicate SD n = 3 (*p &lt; 0.05). <br />                                                            Figure S7. <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                                     Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                          Page 28 <br /> Europe PMC Funders Author Manuscripts <br /> Europe PMC Funders Author Manuscripts <br />  <br />  <br />  <br />  <br />                                                            Figure 7. eEF2K Ortholog efk-1 Supports Survival C. elegans ND Vivo <br />                                                              Lifespans C. elegans WT (N2) efk-1 (ok3609) homozygous deletion mutants <br />                                                            ambient growth conditions. <br />                                                            (B) Lifespans N2 efk-1 (ok3609) mutants L1 stage development                                                            indicated days absence food. Error bars indicate SEM n = 142&#226;&#8364;&#8220;150. <br />                                                            (C) Quantitative RT-PCR efk-1 mRNA levels N2 worms held L1 stage 24 hr <br />                                                            absence food (starved) placed food (OP50 bacteria) 3 hr (fed). <br />                                                            Transcript levels normalized &#206;&#179;-tubulin (tbg-1) levels. Error bars indicate SD n = <br />                                                            3 (*p &lt; 0.05). <br />                                                            (D) Quantitative RT-PCR eEF2K transcripts indicated mammalian cell lines <br />                                                            grown complete media (Ctrl) ND 24 hr. Transcript levels normalized  <br />  <br />                                                                    Cell. Author manuscript; available PMC 2015 April 14. <br />                                          Leprivier et al.                                                                                          Page 29 <br />  <br />  <br />                                                            &#206;&#178;-actin (actb). Results shown relative levels ND versus control conditions                                                            cell line. Error bars indicate SD n = 2 (*p &lt; 0.05). <br />                                                            (E) Model proposed role eEF2K/efk-1 adaptation ND normal tumor <br />                                                            tissues. <br /> </body></html>